// App-Quantinova.ai

e14099 : The role of an open-label non-intervention design versus a placebo-control arm in oncology randomized trials.

Researchers

Presenter

  • Igal Kushnir

Principal Investigators

  • Mark J. Clemons

  • Dean Fergusson

  • Dominick Bosse

  • M. Neil Reaume

Medical Centers

  • Meir Medical Center, Tel Aviv University, Kfar Saba, Israel

  • Ottawa Hospital Cancer Center, University of Ottawa, Ottawa, ON, Canada

  • Clinical Epidemiology Program, The Ottawa Hospital Research Institute and University of Ottawa, Ottawa, ON, Canada

  • Ottawa Hospital Cancer Centre, Ottawa, ON, Canada

Locations

  • Israel

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Open Label

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved